Codexis, Inc. (CDXS) Stock Price
CDXSStock
$1.68−42.56%52W
Market Cap$183.97M
P/E—
PEG Ratio13.53
Div yield—
Beta2.52
CDXS Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)30.63%
Price vs S&P 500 (4W)7.61%
PEG Ratio13.53
VGM Score46.78
CDXS Earnings Surprise History
Q2 25-0.16est. -0.15
Q3 25-0.22est. -0.15
Q4 250.14est. -0.04
Q1 26-0.10est. -0.10
Q2 26-0.13est. -0.12
CDXS Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.08
4.08
4.08
4.08
Industry Peers — Industrial Chemicals(25)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CDXSCodexis, Inc. | C | C | C | $1.68 |
| IFFInternational Flavors & Fragrances Inc. | C | D | B | $87.16 |
| LYBLyondellBasell Industries N.V. Class A | B | D | C | $62.55 |
| WLKWestlake Corporation | C | C | D | $74.80 |
| NEUNewMarket Corporation | C | C | B | $930.72 |
| SXTSensient Technology Corporation | D | C | B | $136.84 |
| MEOHMethanex Corp | B | B | B | $57.08 |
| REXREX American Resources Corp. | B | B | C | $41.51 |
| GPREGreen Plains, Inc. | B | D | C | $14.65 |
| WLKPWESTLAKE CHEMICAL PARTNERS LP | A | C | C | $21.62 |
| BAKBraskem S.A. American Depositary Shares (Each representing Two Class A Preferred Shares) | C | D | D | $1.63 |
About Codexis, Inc.
Codexis develops proprietary enzymatic solutions for biopharmaceutical and diagnostics manufacturing using its CodeEvolver technology platform. The company's enzymes improve production efficiency through higher yields and reduced energy consumption while enabling scaled manufacturing of RNAi therapeutics via its ECO Synthesis platform. Applications span small molecule pharmaceuticals, nucleic acid synthesis, and genomic diagnostics, with primary revenue generation from the Americas.